Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
China flag China · Delayed Price · Currency is CNY
3.430
+0.070 (2.08%)
Apr 29, 2026, 3:04 PM CST

SHE:300026 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Dec '21 2020 - 2016
Cash & Equivalents
1,5021,3061,5741,2061,316
Upgrade
Cash & Short-Term Investments
1,5021,3061,5741,2061,316
Upgrade
Cash Growth
15.00%-17.00%30.46%-8.34%16.89%
Upgrade
Accounts Receivable
2,5722,8252,8923,5463,694
Upgrade
Other Receivables
33.6138.3450.0949.9459.23
Upgrade
Receivables
2,6062,8642,9423,5963,753
Upgrade
Inventory
1,3711,7491,9612,2141,305
Upgrade
Prepaid Expenses
-12.513.2532.1116.77
Upgrade
Other Current Assets
237.67217.18230.06336.93416.22
Upgrade
Total Current Assets
5,7176,1496,7207,3856,806
Upgrade
Property, Plant & Equipment
2,9533,1493,2423,3222,901
Upgrade
Long-Term Investments
178.84235.58247.62244.03272.82
Upgrade
Goodwill
635.6675.2692.54716.05716.05
Upgrade
Other Intangible Assets
267.14298.45331.11352.73313.68
Upgrade
Long-Term Accounts Receivable
-26.3946.3794.1115.01
Upgrade
Long-Term Deferred Tax Assets
223.41222.17129.29140.56108.16
Upgrade
Long-Term Deferred Charges
393.4386.75402.6327.29311.53
Upgrade
Other Long-Term Assets
23.2622.7723.1477.6862.51
Upgrade
Total Assets
10,39211,16511,83512,66011,607
Upgrade
Accounts Payable
449.97678.15713.45884.77605
Upgrade
Accrued Expenses
42.6299.23184.08444.37519.36
Upgrade
Short-Term Debt
14.8516.2423.18231.47293.79
Upgrade
Current Portion of Long-Term Debt
153.41150.25167.67380.77100.02
Upgrade
Current Portion of Leases
-45.2525.8855.0745.86
Upgrade
Current Income Taxes Payable
60.4419.420.619.8215.12
Upgrade
Current Unearned Revenue
52.0363.9776.27208.03137.56
Upgrade
Other Current Liabilities
508.35348.67353.7463.6341.56
Upgrade
Total Current Liabilities
1,2821,6211,5652,6782,058
Upgrade
Long-Term Debt
260.59529.171,2571,3451,458
Upgrade
Long-Term Leases
102.25111.1659.4278.1267.07
Upgrade
Long-Term Unearned Revenue
62.0365.5662.5662.0467.55
Upgrade
Long-Term Deferred Tax Liabilities
31.2839.5223.233.813.95
Upgrade
Total Liabilities
1,7382,3672,9674,1973,655
Upgrade
Common Stock
3,0043,0043,0043,0043,004
Upgrade
Additional Paid-In Capital
589.89589.89589.49589.49589.49
Upgrade
Retained Earnings
4,9715,0435,1124,6954,199
Upgrade
Comprehensive Income & Other
-48.796.834.750.86-19.98
Upgrade
Total Common Equity
8,5178,6448,7108,2907,773
Upgrade
Minority Interest
137.68154.66157.7172.87179.49
Upgrade
Shareholders' Equity
8,6548,7998,8688,4637,952
Upgrade
Total Liabilities & Equity
10,39211,16511,83512,66011,607
Upgrade
Total Debt
531.1852.071,5332,0911,965
Upgrade
Net Cash (Debt)
971.06454.1240.24-884.45-648.87
Upgrade
Net Cash Growth
113.83%1028.45%---
Upgrade
Net Cash Per Share
0.530.210.01-0.30-0.22
Upgrade
Filing Date Shares Outstanding
-3,0043,0043,0043,004
Upgrade
Total Common Shares Outstanding
-3,0043,0043,0043,004
Upgrade
Working Capital
4,4354,5285,1554,7074,748
Upgrade
Book Value Per Share
-2.882.902.762.59
Upgrade
Tangible Book Value
7,6147,6707,6867,2216,743
Upgrade
Tangible Book Value Per Share
-2.552.562.402.24
Upgrade
Buildings
-1,9861,9881,7301,651
Upgrade
Machinery
-2,5442,5142,1551,852
Upgrade
Construction In Progress
-104.1954.11461.01232.93
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.